1-15 of 43268 results
Fleming Europe - Business-to-Business Events and Training
Serving the need for information and knowledge sharing for over six years, Fleming Europe has become one of the most important business intelligence companies delivering quality business-to-business (B2B) events worldwide.
Contract Research & Services > Contract Research > Suppliers
Contract Research & Services > Contract Research > Suppliers
ASEBIO Report 2010
The most salient indicators include the almost 7% rise in the number of biotech R&D personnel employed and the over 5% growth in private R&D expenditure. In addition, companies carrying out biotechnology R&D grew 12%. Other output indicators are also noteworthy, such as the number of patent applications, which virtually doubled (up 85% in the past year). These indicators confirm the efficiency and strength of the national bioindustry sector.
White Papers
White Papers
S1 Biopharma forays into male sexual health
S1 Biopharma, an early-stage biopharmaceutical company, has announced its foray into male sexual health with S1P-205, the drug in development to treat Hypoactive Sexual Desire Disorder (HSDD) in males.
Drug Research > Drug Discovery & Development > News
Drug Research > Drug Discovery & Development > News
Pulmatrix iSPERSE demonstrates capability to formulate drugs
Pulmatrix has demonstrated iSPERSE capabilities for inhaled dry powder delivery of antibiotics, antibodies and other macromolecules.
Drug Research > Drug Delivery > News
Drug Research > Drug Delivery > News
Pernix Therapeutics to implement Ross Enterprise solution
Pernix Therapeutics Holdings, a specialty pharmaceutical company, is planning to deploy CDC Software's Ross Enterprise.
Automation > IT & Software > News
Automation > IT & Software > News
AIS HMI terminals optimize CIP in pharmaceutical plants
American Industrial Systems (AIS) is promoting Hygiene and Cleanliness-compliant operator interface terminal solutions for cleaning-in-place (CIP) in pharmaceutical, food and beverage processing plants.
Production & Manufacturing > Process & Production > News
Production & Manufacturing > Process & Production > News
Reagents for Fine Organic Synthesis – Building Blocks
Renowned for supply of quality screening compound libraries, Enamine, a globally operating medicinal chemistry driven CRO, has developed the world’s largest catalogue of in-house designed and synthesized Building Blocks to complement its large offering of products for early stage drug discovery projects. The company pioneered the Building Block market in the early 2000’s capitalizing on its increasing chemistry experience and the growing number of Building Blocks it had synthesized for library design and numerous synthesis programs.
White Papers
White Papers
Pre-Packaged Diversity Sets of Compounds for Screening
Built on pharmacological profile of compounds rather than on their chemical structure Pharmacological Diversity Set is a brand new tool for HTS campaigns.
White Papers
White Papers
Collection of Compounds for High-Throughput Screening
Enamine’s collection of 1.8 million screening compounds is the world’s largest and most reputable source of small molecules for drug discovery. The majority of the compounds have been synthesized in-house within last 10 years. Each year ca. 200,000 new compounds are added to our collection making it always fresh and interesting for the search of new leads.
White Papers
White Papers
In-Stock-Tomorrow Tangible Structures – REAL Database
REAL DataBase (RDB) is the array of 16 million feasible diverse drug-like structures. The
compounds are synthesized in only 1 step using thoroughly protocolled chemical procedures
from available building blocks.
White Papers
White Papers
Library of Compounds for Fragment-Based Drug Design
The fragment-based approach to drug discovery (FBDD) has been established as an efficient tool in the search for new drugs.1,2 It has been often used since the late 1990s.3 Nowadays a few compounds discovered by FBDD are entering the clinic.4 FBDD has emerged as an alternative approach to traditional lead identification via high-throughput
screening (HTS).
White Papers
White Papers
Pharmacological Diversity Set and 3D Diversity Set
Three-dimensional shape is an essential property of molecules determining their principal ability to bind to biological targets. To maximize biological relevance of a compound library we sought to use this fundamental property in combination with other design approaches.
White Papers
White Papers
Pernix launches new therapy to eradicate H. pylori
Pernix Therapeutics Holdings has launched Omeclamox-Pak, a ten-day therapy, to eradicate Helicobacter pylori (H. pylori) in adult patients.
Drug Research > Drug Discovery & Development > News
Drug Research > Drug Discovery & Development > News
PBR Supplier Recommendations
Serving the need for information and knowledge sharing for over six years, Fleming Europe has become one of the most important business intelligence companies delivering quality business-to-business (B2B) events worldwide. ... Contract Research & Services > Contract Research > Suppliers CitySprint Healthcare - Healthcare Delivery, Distribution and Logistics Network
CitySprint Healthcare is a division of CitySprint, the UK's largest privately owned same day distribution network offering SameDay Courier, SameDay Logistics, International courier and UK overnight services on a 24/7 basis. With our extensive network of 35 service centres across the UK and fleet of over 2000 vehicles, we are able to provide a secure and rapid service which manages 3 million critical deliveries each year for our clients.... Suppliers IDT - Biopharmaceutical Development & Contract Manufacturing Services
IDT Biologika is an innovative, privately-held company with more than 90 years of experience in researching, developing, manufacturing and marketing of biologics. IDT operates one of Europe’s premiere integrated biological and pharmaceutical development and manufacturing facilities.... Production & Manufacturing > Manufacturing > Suppliers Sofrigam - Industrial Insulated and Refrigerated Packaging
Sofrigam designs and qualifies isothermal and refrigerated packaging enabling the transport of heat sensitive products in non-refrigerated vehicles.... Suppliers Helsinn Advanced Synthesis- Shaping Alliances Building Pharmaceuticals
Helsinn Advanced Synthesis focuses on process development and scale-up for exclusive cGMP manufacturing offering comprehensive support services for small and large pharmaceutical partners developing new chemical entities (NCEs)... Production & Manufacturing > Fine & Speciality Chemicals > Suppliers See more
PBR White Paper Recommendations
The most salient indicators include the almost 7% rise in the number of biotech R&D personnel employed and the over 5% growth in private R&D expenditure. In addition, companies carrying out biotechnology R&D grew 12%. Other output indicators are also noteworthy, such as the number of patent applications, which virtually doubled (up 85% in the past year). These indicators confirm the efficiency and strength of the national bioindustry sector.... White Papers Map Members 16 May 2012 | By ASEBIO White Papers Biomolecular Screening and ADMET services 16 May 2012 | By Enamine White Papers Reagents for Fine Organic Synthesis – Building Blocks 16 May 2012 | By Enamine
Renowned for supply of quality screening compound libraries, Enamine, a globally operating medicinal chemistry driven CRO, has developed the world’s largest catalogue of in-house designed and synthesized Building Blocks to complement its large offering of products for early stage drug discovery projects. The company pioneered the Building Block market in the early 2000’s capitalizing on its increasing chemistry experience and the growing number of Building Blocks it had synthesized for library design and numerous synthesis programs. ... White Papers Pre-Packaged Diversity Sets of Compounds for Screening 16 May 2012 | By Enamine
Built on pharmacological profile of compounds rather than on their chemical structure Pharmacological Diversity Set is a brand new tool for HTS campaigns.... White Papers See more
